Constance John
6Patents
2h-index
8Co-inventors
40Inventor score
Filing activity: Jun 8, 2001 → Jun 18, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6770622B2 | N-terminally truncated galectin-3 for use in treating cancer | Human Necessities | 17 | Expired |
| US9272014B2 | Galectin-3C combination therapy for human cancer | Human Necessities | 3 | Active |
| US10369195B2 | Methods and compositions for preventing and treating damage to the heart | Human Necessities | 1 | Active |
| US9744212B2 | Galectin-3C combination therapy for human cancer | Human Necessities | 1 | Active |
| US11179439B2 | Methods and compositions for preventing and treating damage to the heart | Human Necessities | 0 | Active |
| US10851348B2 | Proliferative primary human Sertoli cell cultures and their applications | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.